Matteo Massidda is currently a Researcher of the Next Generation Sequencing Core program at CRS4.
After obtaining a Master's degree in Cellular and Molecular Biology at the University of Cagliari, he has carried out research at the Genetics and Genomics laboratory of the Hospital Microcitemico A. Cao (Cagliari, Italy). He received his PhD in Molecular and Translational Medicine from the University of Cagliari in the year 2018. His doctoral research investigated the application of NGS technology to the non-invasive prenatal diagnosis of beta-thalassemia. During his PhD he has also gained experience at the Centro Nacional de Análisis Genómico CNAG-CRG (Barcelona, Spain) working on single-cell transcriptome data analysis.
Since September 2018 he has been working at CRS4 as a research fellow (PATH project - "Pathology Automatic Traceable Healthcare"), focusing on the bioinformatics analysis of NGS data and on the development of high processivity pipelines specialized in genome, exome and transcriptome analysis. More recently Matteo contributed to the development of a NGS-based screening test for COVID-19.